Goetzel Ron Z, Ozminkowski Ronald J, Villagra Victor G, Duffy Jennifer
Institute for Health and Productivity Studies, Cornell University Institute for Policy Research, Medstat, Washington, DC 20008, USA.
Health Care Financ Rev. 2005 Summer;26(4):1-19.
The results of 44 studies investigating financial impact and return on investment (ROI) from disease management (DM) programs for asthma, congestive heart failure (CHF), diabetes, depression, and multiple illnesses were examined. A positive ROI was found for programs directed at CHF and multiple disease conditions. Some evidence suggests that diabetes programs may save more than they cost, but additional studies are needed. Results are mixed for asthma management programs. Depression management programs cost more than they save in medical expenses, but may save money when considering productivity outcomes.
对44项研究的结果进行了审查，这些研究调查了针对哮喘、充血性心力衰竭（CHF）、糖尿病、抑郁症和多种疾病的疾病管理（DM）项目的财务影响和投资回报率（ROI）。针对CHF和多种疾病状况的项目发现了正的投资回报率。一些证据表明，糖尿病项目可能节省的费用超过其成本，但还需要更多研究。哮喘管理项目的结果好坏参半。抑郁症管理项目在医疗费用方面成本高于节省的费用，但在考虑生产力成果时可能节省资金。
